Search Results - "V.Y. Susilo"

Uptake and Cytotoxicity Characterization of Radioiodine in MCF-7 and SKBR3 Breast Cancer Cell Lines by Elliyanti, A., Susilo, V.Y., Setiyowati, S., Ramli, M., Masjhur, J.S., Achmad, T.H.

“…Radioiodine is an effective and low-risk therapy modality in well-differentiated thyroid cancer patients post near-total thyroidectomy. Extra thyroidal tumors…”
Get full text

Fragmentation of Nimotuzumab for Preparation of 125I-F(ab’)2-Nimotuzumab as a Precursor for Preparing 125I-F(ab’)2-Nimotuzumab-NLS Radiopharmaceutical for Cancer Therapy by Haryuni, R.D., Bahtiar, A., Soenarjo, S., Harahap, Y., Mutalib, A., Ramli, M., Hermanto, S., Ardiyatno, C.N., Susilo, V.Y., Haffid, D.

“…Nimotuzumab is an anticancer agent which belongs to the inhibitor group of Epidermal Growth Factor Receptor (EGFR). This monoclonal antibody has a relatively…”
Get full text

Synthesis of Sulochrin-125I and Its Binding Affinity as α-Glucosidase Inhibitor using Radioligand Binding Assay (RBA) Method by Lestari, W., Susilo, V.Y., Setiyowati, S., Triningsih, Triningsih, Ariyanto, A., Widayati, P., Kardono, L.B.S., Yanuar, A.

Get full text

Synthesis of Sulochrin-125I and Its Binding Affinity as α-Glucosidase Inhibitor using Radioligand Binding Assay (RBA) Method by W. Lestari, V.Y. Susilo, S. Setiyowati, Triningsih, A. Ariyanto, P. Widayati, L.B.S. Kardono, A. Yanuar3

“…Most of diabetics patients have type 2 diabetes mellitus or non insulin dependent diabetes mellitus. Treatment type 2 diabetes mellitus can be done by…”
Get full text